Beech Tree Labs, Inc.
bioregulatory molecules that modulate biological pathways to treat disease
- Sector
- Biotech
- Headquarters
- DELANSON, NY
- Latest Form D
- $125K, Sep 2015
- Total capital
- $1.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.7M
- 3 Form D · last Sep 2015
- 133 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 20 pending · first 2015
- Rank in peer group#397 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$125K
- Private capital raisedForm D · SEC · 2nd filing$125K
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#397 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- John McMichaelResearcherExecutive Officer, DirectorLinked by 2 patents
- Arthur de Witt AckermanDirectorNamed in SEC Form D filings
- H.W. I. McKay BelkDirectorNamed in SEC Form D filings
- Jeffrey A. EckmannDirectorNamed in SEC Form D filings
- John I. GlassonDirectorNamed in SEC Form D filings
- John A. RossDirectorNamed in SEC Form D filings
Show all 10 people
- Robert I. KramerDirectorNamed in SEC Form D filings
- Sheridan C. BiggsDirectorNamed in SEC Form D filings
- Thomas A. HatchExecutive OfficerNamed in SEC Form D filings
- William de Witt RyanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 22- PendingMethod Of Treating Coronavirus Infection By Administration Of Ethyl Mercury Or Thiol Derivative ThereofUSPTOApplication 17913086
- GrantedMethod Of Inhibiting Microglial Cell Migration And Treating Traumatic Brain InjuryUSPTOUS 10,213,480
- PendingMethod of treating central nervous system disorders with Borrelia burgdorferi antigenUSPTOApplication 14704084
Show all 22 patent records
- Method Of Treating Coronavirus Infection By Administration Of Ethyl Mercury Or Thiol Derivative ThereofDec 14, 2023 · Application 17913086Pending
- Method Of Inhibiting Microglial Cell Migration And Treating Traumatic Brain InjuryFeb 26, 2019 · US 10,213,480Granted
- Method of treating central nervous system disorders with Borrelia burgdorferi antigenNov 12, 2015 · Application 14704084Pending
- Method of Treating Chronic Obstructive Pulmonary DiseaseMar 17, 2015 · US 8,980,826Granted
- Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70)Jul 10, 2014 · Application 13733946Pending
- Method Of Treating Muscular Weakness Comprising Administering A Composition Comprising An Effective Amount Of Histamine And/or SerotoninMay 1, 2014 · Application 14062683Pending
- Method Of Treating Pain By Administration Of Nerve Growth FactorJul 11, 2013 · Application 13735273Pending
- Method of treating central nervous system disorders with Borrelia burgdorferi antigenApplication 61989222Pending
- Method Of Treating Muscular Weakness Comprising Administering A Composition Comprising An Effective Amount Of Histamine And/or SerotoninApplication PCTUS2013066669Pending
- Method Of Treating Chronic Obstructive Pulmonary DiseaseApplication PCTUS2013027929Pending
- Method Of Treating Pain By Administration Of Nerve Growth FactorApplication PCTUS2013020463Pending
- Method Of Treating Cancer By Administration Of Low Levels Of Heat Shock Protein 70 (HSP70)Application PCTUS2013020252Pending
- Method Of Treating A Disorder Associated With Sequestered BacteriaApplication PCTUS2012022764Pending
- Method Of Treating Viral Infections By Administration Of Ethyl Mercury Or Thiol Derivative ThereofApplication PCTUS2011029049Pending
- Methods Of Inhibiting Metastatic Cancer By Administration Of Streptolysin OApplication PCTUS2010058421Pending
- Method Of Treating Cravings By Administration Of Nerve Growth FactorApplication PCTUS2010043957Pending
- Method Of Treating Neuroinflammatory Symptoms Of Central Nervous System (cns) Disorders By Administration Of Cholesterol Dependent Cytolysins (cdc)Application 63403227Pending
- Method Of Treating Coronavirus Infection By Administration Of Ethyl Mercury Or Thiol Derivative ThereofApplication PCTUS2021023846Pending
- Method Of Treating Coronavirus Infection By Administration Of Ethyl Mercury Or Thiol Derivative ThereofApplication 63001086Pending
- Methods Of Treating A Traumatic Brain InjuryApplication PCTUS2016026330Pending
- Method Of Treating Traumatic Brain Injury By Administration Of Steptolysin OApplication 62144590Pending
- Method of treating central nervous system disorders with Borrelia burgdorferi antigenApplication 62007715Pending
Related companies, and why
- Xenagos Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Peloton Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- OWIC TECHNOLOGIES, INC.Similar federal contract value in Biotech · null in contracts
- TRIO PHARMACEUTICALS INC.Similar federal contract value in Biotech · null in contracts
- Asha Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- BIOCOLLECTIVE, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .